Talphera
TLPH | NASDAQ
$0.86
-$0.05 (-5.08%)
At close: Nov 16, 2026, 4:00 PM ET
$0.86
$0.00 (+0.10%)
After-hours:
Nov 16, 2026, 5:11 PM ET
-5.08%
(1D)No price chart data available for 1D timeframe.
Rating
33.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #708/1021 (Top 69%)
Key Statistics
Market Data
Market Cap $64.97M
1D Range
0.83 0.89
52W Range
0.72 1.47
Valuation (TTM)
PE -3.31
PB 6.06
EV/EBITDA -3.71
Valuation (NTM)
Forward PE N/A
Forward PEG 0.08
Price Target $3.00
Cash Flow
FCF Yield -19.7%
SBC Adj. FCF Yield -21.1%
SBC Impact -7.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -136.4% |
-57.8%
Dil EPS 3Y | 5Y 48.5% |
-174.1%
FCF 3Y | 5Y 6.2% |
25.3%
Returns
ROA -62.2%
ROE -96.7%
ROIC -81.6%
Financial Health
Net Cash
$14.16M
Current Ratio 3.19
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products intended for use in carefully monitored medical environments. Their lead experimenta...
Sector Healthcare
Employees 12
IPO Date Feb 11, 2011
Website talphera.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove TLPH